'Govt Should Act Early To Buy New Covid Drug'
"); jQuery("#212 h3").html("
"); jQuery(document).ready(function() { jwplayer.key='EKOtdBrvhiKxeOU807UIF56TaHWapYjKnFiG7ipl3gw='; var playerInstance = jwplayer("jquery_jwplayer_1"); playerInstance.setup({ file: "https://newsstatic.rthk.hk/audios/mfile_1613381_1_20211004101029.mp3", skin: { url: location.href.split('/', 4).join('/') + '/jwplayer/skin/rthk/five.css', name: 'five' }, hlshtml: true, width: "100%", height: 30, wmode: 'transparent', primary: navigator.userAgent.indexOf("Trident")>-1 ? "flash" : "html5", events: { onPlay: function(event) { dcsMultiTrack('DCS.dcsuri', 'https://news.rthk.hk/rthk/en/component/k2/1613381-20211004.mp3', 'WT.ti', ' Audio at newsfeed', 'WT.cg_n', '#rthknews', 'WT.cg_s', 'Multimedia','WT.es','https://news.rthk.hk/rthk/en/component/k2/1613381-20211004.htm', 'DCS.dcsqry', '' ); } } }); }); });
2021-10-04 HKT 10:09
Share this story
William Chui speaks to Wendy Wong
A pharmacists’ association said on Monday that a new drug for Covid-19 could help relieve the burden on hospitals if Hong Kong sees another outbreak of infections, adding that the government should act early to ensure the city is able to procure the medication.
The Society of Hospital Pharmacists of Hong Kong has welcomed the Hospital Authority’s plan to buy 500 courses of molnupiravir – the first oral antiviral medication for Covid-19 developed by a US drug maker.
Interim clinical trial results suggest the pills can cut the risk of hospitalisation by half.
Speaking on an RTHK programme, the society's president, William Chui, said although Hong Kong has had no local Covid cases for some time, it's a good idea for the government to approach the drug company early, as other countries are expected to compete for the new medication.
“This is a good start. I don’t think the government should wait and see because it would be too late as many countries already started to procure the new drug,” he said.
But University of Hong Kong microbiologist Ho Pak-leung said although the interim results were encouraging, trials for the drug were still incomplete.
He said the government should adopt a cautious approach and wait for more information on the drug.
Ho stressed that getting vaccinated was still the safest and most effective way to prevent complications and deaths arising from Covid-19.
TOPPAN Edge Becomes Japans First Qualified VLEI Issuer
The Global Legal Entity Identifier Foundation (GLEIF) has announced TOPPAN Edge, a subsidiary of TOPPAN Holdings that p... Read more
SFC And Dubais DFSA Partner On Cross-Border Regulatory Cooperation
The Dubai Financial Services Authority (DFSA), the independent regulator of the Dubai International Financial Centre (D... Read more
Toss To Launch Finance Super-App In Australia, Plans Won-Based Stablecoin
South Korea’s fintech unicorn Toss is preparing to launch its finance super-app in Australia before the end of this y... Read more
China Funds Research On Stablecoins And Cross-Border Oversight
China’s largest government-backed research funder has begun accepting applications for studies on stablecoins and the... Read more
XTransfer, CZBank Shanghai Branch Form Cross-Border Finance Partnership
XTransfer has entered into a partnership with the Shanghai branch of China Zheshang Bank (CZBank). The agreement was si... Read more
Brinc Launches VentureVerse Through Acquisition Of OG Club
Brinc, a Hong Kong-based venture acceleration and corporate innovation firm, has acquired OG Club, a decentralised auto... Read more